UPDATE -- Quark Branches into New Era of Content Intelligence with Release of Quark Publishing Platform NextGen v3.0
Self-service content automation platform streamlines enterprise content workflows with deeper analytics to measure content consumption patterns
In a release issued earlier today by Quark Software, the company is updating this release to include link for https://developer.quark.com
GRAND RAPIDS, Mich., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Quark Software, the global provider of content automation, intelligence and design software, today announced the newest release of Quark Publishing Platform (QPP) NextGen, its content automation platform designed to simplify the complexities associated with enterprise content lifecycle management from creation to consumption. QPP NextGen v3.0 takes self-service a giant step further with simplified role-based dashboards and now includes enhanced analytics capabilities to help enterprises accurately understand how published content is being consumed. Additional new features foster content team collaboration and productivity with the power to publish personalized, compliance-controlled content across any digital output fast.
“As global enterprises begin to understand the role content plays in supporting business growth, it brings to light the importance of modernizing content infrastructures and processes, and knowing how content is being consumed by their target audiences,” said Martin Owen, CEO at Quark. “Executing a successful content strategy is complex, and your content operations infrastructure is at the heart of this success. QPP NextGen has all the tools to automate each stage of the content lifecycle. For the first time, enterprises can move faster to market with compliance-controlled, omnichannel content with easy access to deep analytics to gain content consumption metrics and understand if their content really works for their business.”
According to a Forrester blog, The Quantum Physics of Future-Ready B2B Content, B2B organizations know that the digital experiences they deliver must be relevant and fueled with audience-centric content. However, fewer than 30% plan to focus on real-time, contextualized interaction capabilities in the next 12 months, although 74% recognize that buyers expect personalized interactions. Additionally, a recent IDC blog discusses the importance of organizations evaluating how they manage business content operations and the value of what they call a Unified Content Model brings to supporting their digital first business.
Quark has been in the content technology business for over 40 years and knows that content delivered must be personalized and reach the right audience at the right time and via the right device for optimal consumption. Quark understands that many organizations don’t know if their content is achieving the desired results and cannot measure true content ROI.
QPP NextGen addresses these complexities with automation capabilities to support multiple use cases with the power to manage large, complex documents at scale. Enterprises can create, manage and store structured, reusable content components with auto-generated XML metadata tags from Microsoft Word, collaborate across roles and departments to streamline reviews/approvals and eliminate duplicate efforts, and publish compliance-controlled content in multiple formats from a single source-of-truth CCMS with 100% accuracy.
New features and benefits available in the newest release of QPP NextGen include:
- Granular Section-Level Analytics & Visual Intelligence– In addition to seeing content consumption patterns of an overall asset, organizations can understand how many individual components and sections of an asset are being consumed the most, with visibility into consumption analytics for each one. This helps organizations make smarter content creation and delivery decisions, and better understand when to reuse, repurpose or retire content. Newly available visual reports help content creators understand content success, trends and engagement patterns through easy-to-understand visuals such as charts and graphs.
- Enriched UI - Team Collaboration and Workflow Productivity Enhancements – A personalized, streamlined UI delivers a single pane of glass view to easily address any stage – or all stages - of the content lifecycle. Users receive alerts for priority content workflows that need fast attention.
- Interoperability of Structured Authoring Tools – To support a global workforce, content teams can collaborate in real-time between low-code / no-code Microsoft Word and Web browser authoring tools to maximize workflow productivity.
- Version Branching – Content creators can expand content reach by creating regionalized, personalized and localized versions of content by cloning and branching off new ‘child components’ that are linked to original content.
- Self-Service Content Modeling – SMEs can make real-time changes to content models, XML schematic architecture and format styles to support emerging document types, including regulatory changes and layout adjustments.
- Learn more about Quark Publishing Platform and request a demo.
- Learn how to use QPP NextGen’s open architecture to connect your wider ecosystem or create extensions at https://developer.quark.com
- Content Automation: The Essential Ingredient for a Successful, Agile Content Lifecycle Management Ecosystem white paper
- Read The Quark Blog.
- Learn more about our events that discuss all things enterprise content lifecycle management.
About Quark Software, Inc.
Quark knows content. The company revolutionized desktop publishing and today provides content automation, intelligence and design software for end-to-end content lifecycle management. Customers worldwide rely on Quark to modernize their content ecosystems so they can automate omnichannel publishing of mission-critical documents, analyze production and engagement insights for the greatest return on their content investments, and create complex print and digital layouts. Quark is backed by Parallax Capital Partners and headquartered in Grand Rapids, Mich., with offices in the United Kingdom, Ireland and India. Quark. Brilliant content that works. For more information, visit www.quark.com or follow us on LinkedIn.
Corporate Communications, Quark
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Biogen Provides Update on FDA Advisory Committee Meeting on Tofersen for SOD1-ALS23.3.2023 01:31:57 CET | Press release
SOD1-ALS is a rare genetic form of the disease affecting approximately 330 people in the United States CAMBRIDGE, Mass., March 22, 2023 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) announced today the outcome of the U.S. Food and Drug Administration’s (FDA) Peripheral and Central Nervous System Drugs Advisory Committee meeting on tofersen, an investigational product for the treatment of superoxide dismutase 1 (SOD1) amyotrophic lateral sclerosis (ALS). On the question, “Is the available evidence sufficient to conclude that a reduction in plasma neurofilament light chain (NfL) concentration in tofersen-treated patients is reasonably likely to predict clinical benefit of tofersen for treatment of patients with SOD1-ALS?” the Committee voted unanimously yes (9 yes to 0 no), for consideration of a potential accelerated approval. On the second question, “Does the clinical data from the placebo-controlled study and available long-term extension study results, with additional supporting res
GN Store Nord announces change to the Board of Directors22.3.2023 22:22:29 CET | Press release
Due to sudden serious health issues in the family, Montserrat Maresch Pascual has decided to step down from the Board of Directors of GN Store Nord A/S. The Chairmanship assesses that the remaining five members of the Board possess all the relevant competencies and experience to govern the company. Consequently, GN’s Board of Directors as of today consists of Jukka Pekka Pertola (Chair), Klaus Holse (Deputy chair), Anette Weber, Hélène Barnekow, Ronica Wang, and members elected by the employees: Leo Larsen, Cathrin Inge Hansen, and Claus Holmbeck-Madsen. For further information, please contact: Investor Relations Anne Sofie Staunsbæk Veyhe +45 45 75 85 06 Rune Sandager +45 45 75 92 57 Media Relations Steen Frentz Laursen +45 20 65 34 20 About GN GN facilitates communication between people through intelligent hearing, audio, video, and gaming technology. Inspired by people and driven by our passion for innovation, we leverage technologies to deliver unique user experiences that bring pe
ERYTECH Provides Business and Financial Update for the Fourth Quarter and Full Year 202222.3.2023 22:05:00 CET | Press release
ERYTECH Provides Business and Financial Update for the Fourth Quarterand Full Year 2022 Combination with Pherecydesannounced, intending to create a global leader in extended phage therapies targeting antimicrobial resistant pathogenic bacteria Deep restructuring implemented; team size reduced by approximately 75% since start of 2022Cash and cash equivalents of €38.8million ($41.5 million) at the end of December 2022 Cambridge, MA (U.S.) and Lyon (France),March 22, 2023– ERYTECH Pharma (Nasdaq & Euronext: ERYP),aclinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today provided a business and financial updatefor thefourth quarterand full year of2022. “After the disappointing results of our Phase 3 trial in pancreatic cancer, we have pursued during 2022 a consistent strategy to maximize the remaining value for our shareholders through strategic partnering. We sold our US manufacturing site, sharply
Hvidbjerg Banks ordinære generalforsamling den 22. marts 202322.3.2023 21:48:49 CET | pressemeddelelse
Formand Henrik H. Galsgaard udpegede advokat Rasmus Kronborg, Thisted til dirigent i henhold til vedtægternes § 9. Rasmus Kronborg takkede for valget og konstaterede, at generalforsamlingen var korrekt indvarslet og beslutningsdygtig med hensyn til generalforsamlingens dagsorden, som blev gennemgået. Dagsordenens punkt 1: Formand Henrik H. Galsgaard aflagde på bestyrelsens vegne mundtlig beretning om bankens virksomhed i det forløbne år. På grund af kommende kapitalkrav forventes der ikke udbetalt udbytte i de kommende år. Der var ikke kommet bemærkninger eller spørgsmål, hvorefter dirigenten konstaterede, at beretningen var taget til efterretning. Dagsordenens punkt 2 og 3: Bankdirektør Jens Odgaard fremlagde årsrapporten til godkendelse og årsrapporten blev godkendt. Årets resultat t.kr. 25.172 blev vedtaget overført således: Udbytte 0 Rente hybrid kernekapital 975 Henlagt til egenkapitalen 24.197 I alt anvendt 25.172 Dagsordenens punkt 4: Bestyrelsesformand Henrik H. Galsgaard freml
CNH Industrial: Periodic Report on $300 Million Buyback Program. Completion of Second $50 million tranche and launch of Third $50 million tranche22.3.2023 21:30:00 CET | Press release
London, March 22, 2023 CNH Industrial N.V. (NYSE: CNHI / MI: CNHI) announces that it has completed the second tranche of its $50 million share buyback (the “Second Tranche”) in the framework of its $300 million common share buyback program with the transaction described in the table below. The transaction, completed on March 13, 2023, reported in aggregate, was based on automatic orders placed with the Company’s broker (who made its trading decisions as to the timing of the purchases independently of the Company based on instructions given before the commencement of the Company’s closed period under the applicable regulations). After the purchases announced today and considering those previously executed under the Second Tranche, the total invested amount is approximately €46,863,453.43 ($49,999,997.50) for a total amount of 3,065,368 common shares purchased. DateNumber of common shares purchasedAverage price per share excluding feesConsideration excluding fees Consideration (**) exclu